References
- Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014 Jul 8;64(1):83–99.
- Olivotto I, Cecchi F, Poggesi C, Yacoub MH. Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Circ Heart Fail. 2012 Jul;5(4):535–46. http://circheartfailure.ahajournals.org
- Kitaoka H, Kubo T, Doi YL. Hypertrophic cardiomyopathy: a heterogeneous and lifelong disease in the real world. Circ J. 2020 Jul 22;84(8):1218–26.
- Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC guidelines for the management of cardiomyopathies: developed by the Task Force on the Management of Cardiomyopathies of the European Society of Cardiology (ESC). Eur Heart J. 2023 Oct 1;44(37):3503–3626.https://dx.doi.org/10.1093/eurheartj/ehad194
- McDonagh TA, Metra M, Adamo M, Baumbach A, Böhm M, Burri H, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599–3726.
- Brenes JC, Doltra A, Prat S. Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy. Glob Cardiol Sci Pract. 2018;2018(3):22. https://pmc.ncbi.nlm.nih.gov/articles/PMC6209443/
- Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC guidelines for the management of chronic coronary syndromes: developed by the Task Force for the Management of Chronic Coronary Syndromes of the European Society of Cardiology (ESC), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024 Sep 29;45(36):3415–3537. https://dx.doi.org/10.1093/eurheartj/ehae177
- Al-Sabeq B, Nabi F, Shah J. Assessment of myocardial viability by cardiac magnetic resonance imaging. Curr Opin Cardiol. 2019 Sep;34(5):502–509. doi:10.1097/HCO.0000000000000656
- Sherrid MV, Bernard S, Tripathi N, Patel Y, Modi V, Axel L, et al. Apical aneurysms and mid–left ventricular obstruction in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging]. 2023 May 1;16(5):591–605. https://scholars.mssm.edu/en/publications/apical-aneurysms-and-midleft-ventricular-obstruction-in-hypertrop
- Vito G, Russo L, Pepi M, Mushtaq S, Mantegazza V, Celeste F. Is there a typical doppler pattern in patients with apical hypertrophic cardiomyopathy with aneurysm? JACC Case Rep. 2023;14:101836.https://doi.org/10.1016/j.jaccas.2023.101836
- Lee DZJ, Montazeri M, Bataiosu R, Hoss S, Adler A, Nguyen ET, Rakowski H, Chan RH. Clinical Characteristics and Prognostic Importance of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2022 Oct;15(10):1696-1711. doi: 10.1016/j.jcmg.2022.03.029
- Rowin EJ, Maron BJ, Haas TS, Garberich RF, Wang W, Link MS, Maron MS. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. J Am Coll Cardiol. 2017 Feb 21;69(7):761-773. doi: 10.1016/j.jacc.2016.11.063. Erratum in: J Am Coll Cardiol. 2017 Mar 28;69(12):1652. doi: 10.1016/j.jacc.2017.02.014